GlassScriptPhysician profile
Kenneth A Essig
NPI 1073519310
$4,032.30
in general payments reported to CMS, 2019-2025
31 companies · $604 in 2025
The $604 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $156 · 2021: $484 · 2022: $479 · 2023: $822 · 2024: $1,185 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,108 · Travel and Lodging: $325 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,108.26 |
| Travel and Lodging | $325.07 |
| Education | $177.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $881.25 | 2019-2024 | |
| Medtronic, INC. | $369.61 | 2021-2023 | Interstim |
| Endo Pharmaceuticals INC. | $355.38 | 2019-2023 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $297.05 | 2020-2024 | Myrisk, Prolaris |
| Endo USA, INC. | $290.65 | 2024-2025 | Xiaflex, Aveed, Edex |
| Pfizer INC. | $266.29 | 2019-2025 | |
| Axonics, INC. | $211.83 | 2021-2023 | Axonics |
| Boston Scientific Corporation | $163.48 | 2019-2024 | Rezum Generator |
| Photocure INC | $136.59 | 2023-2024 | Cysview |
| Antares Pharma, INC. | $122.03 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $121.69 | 2020-2025 | Erleada |
| Sumitomo Pharma America, INC. | $115.76 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $110.47 | 2021 | |
| Seagen INC. | $84.99 | 2025 | |
| Procept Biorobotics Corporation | $83.51 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $70.91 | 2024 | Cure Catheter |
| Karl Storz Endoscopy-America | $55.10 | 2023 | N.A. |
| Urovant Sciences INC | $39.79 | 2022 | |
| Astellas Pharma US INC | $31.84 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $27.33 | 2022-2025 | |
| Novo Nordisk INC | $26.39 | 2019-2025 | Ozempic |
| Lilly USA, LLC | $20.33 | 2023 | Mounjaro |
| Nevro Corp. | $19.95 | 2024 | Senza |
| Urogen Pharma, INC. | $17.37 | 2022 | |
| Travere Therapeutics, INC. | $17.13 | 2019 | |
| Merck Sharp & Dohme LLC | $16.74 | 2022 | |
| Medtronic USA, INC. | $16.74 | 2019 | |
| Calyxo, INC. | $16.43 | 2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $16.29 | 2023 | Pylarify |
| Si-Bone, INC. | $14.82 | 2024 | |
| Dentsply Ih INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Essig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.